a KA (Kaletra 200 mg / 50 mg)

Generic Name: lopinavir/ritonavir

Pill imprint a KA has been identified as Kaletra 200 mg / 50 mg.

Kaletra is used in the treatment of nonoccupational exposure; hiv infection and belongs to the drug class protease inhibitors. Risk cannot be ruled out during pregnancy. Kaletra 200 mg / 50 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for a KA

Kaletra 200 mg / 50 mg a KA  Front
Kaletra 200 mg / 50 mg a KA  Back
Kaletra
Generic Name:
lopinavir/ritonavir
Imprint:
a KA
Strength:
200 mg / 50 mg
Color:
Yellow
Size:
19.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Protease inhibitors
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Abbott Laboratories
National Drug Code (NDC):
00074-6799
Inactive Ingredients:
sorbitan monolaurate
silicon dioxide colloidal
sodium stearyl fumarate
titanium dioxide
polyethylene glycol 400
hydroxypropyl cellulose
magnesium silicate
polyethylene glycol 3350
ferric oxide yellow
polysorbate 80
hypromelloses
copovidone
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54569-5752 A S Medication Solutions LLC (repackager)
54868-5566 Physicians Total Care Inc (repackager)
55045-3482 Dispensing Solutions Inc. (repackager)
55289-0947 PDRX Pharmaceuticals Inc (repackager)
00490-7028 Southwood Pharmaceuticals Inc (repackager)
35356-0112 Lake Erie Medical and Surgical Supply (repackager)
21695-0362 Rebel Distributors Corp (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)